The conundrum of causality in tumor virology: The cases of KSHV and MCV

Seminars in Cancer Biology

Volumn 26, Issue , 2014, Pages 4-12

  Moore, Patrick S ^a   Chang, Yuan ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Cancer virus; Carcinogenic mechanisms; Causal inference; Causality; Kaposi's sarcoma herpesvirus; Merkel cell polyomavirus

Indexed keywords

CAUSAL ATTRIBUTION; DISEASE ASSOCIATION; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; MERKEL CELL POLYOMAVIRUS; MERKEL CELL TUMOR; MULTICENTRIC CASTLEMAN DISEASE; NONHUMAN; NUCLEIC ACID ANALYSIS; POLYOMAVIRUS INFECTION; PRIMARY EFFUSION LYMPHOMA; REVIEW; RISK FACTOR; TUMOR VIRUS; VIROLOGY; VIRUS CARCINOGENESIS; COMPLICATION; HISTORY; NEOPLASMS; PHYSIOLOGY; TUMOR VIRUS INFECTIONS; ACQUIRED IMMUNE DEFICIENCY SYNDROME; CARCINOGENICITY; INFECTION RATE; MOLECULAR PATHOLOGY; ONCOGENE; VIRUS GENOME; VIRUS INFECTION; VIRUS MUTATION;

HERPESVIRUS 8, HUMAN; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; MERKEL CELL POLYOMAVIRUS; NEOPLASMS; ONCOGENIC VIRUSES; TUMOR VIRUS INFECTIONS;

ONCOPROTEIN;

EID: 84901852770     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2013.11.001     Document Type: Review

References (124)

1. de Martel C., Ferlay J., Franceschi S., Vignat J., Bray F., Forman D., et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012, 13:607-615.
2. de Martel C., Franceschi S. Infections and cancer: established associations and new hypotheses. Crit Rev Oncol Hematol 2009, 70:183-194.
3. Frank T. Getting to Eureka. Harper's Mag 2013, 7-9.
4. Epstein M.A., Achong B.G., Barr Y.M. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964, 15:702-703.
5. IARC Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8 1997, World Health Organization, Lyon.
6. Chigwedere P., Seage G.R., Gruskin S., Lee T.H., Essex M. Estimating the lost benefits of antiretroviral drug use in South Africa. J Acquir Immune Defic Syndr 2008, 49:410-415.
7. Duesberg P.H., Mandrioli D., McCormack A., Nicholson J.M., Rasnick D., Fiala C., et al. AIDS since 1984: no evidence for a new, viral epidemic-not even in Africa. Ital J Anat Embryol 2011, 116:73-92.
8. Weiss R.A., Jaffe H.W. Duesberg, HIV and AIDS. Nature 1990, 345:659-660.
9. Duesberg P. HIV is not the cause of AIDS. Science 1988, 241:514-517.
10. Ernberg I., Klein G. Effects on apoptosis, cell cycle and transformation, and comparative aspects of EBV with other DNA tumor viruses. Human herpesviruses: biology, therapy and immunoprophylaxis 2007, 514-539. Cambridge University Press, Cambridge. A. Arvin, G. Campadelli-Fiume, E. Mocarski, P.S. Moore, B. Roizman, R. Whitley (Eds.).
11. Rawls W.E., Tompkins W.A., Figueroa M.E., Melnick J.L. Herpesvirus type 2: association with carcinoma of the cervix. Science 1968, 161:1255-1256.
12. McDougall J.K., Crum C.P., Fenoglio C.M., Goldstein L.C., Galloway D.A. Herpesvirus-specific RNA and protein in carcinoma of the uterine cervix. Proc Natl Acad Sci U S A 1982, 79:3853-3857.
13. Durst M., Gissmann L., Ikenberg H., zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A 1983, 80:3812-3815.
14. Boshart M., Gissmann L., Ikenberg H., Kleinheinz A., Scheurlen W., zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 1984, 3:1151-1157.
15. Paprotka T., Delviks-Frankenberry K.A., Cingoz O., Martinez A., Kung H.J., Tepper C.G., et al. Recombinant origin of the retrovirus XMRV. Science 2011, 333:97-101.
16. Urisman A., Molinaro R.J., Fischer N., Plummer S.J., Casey G., Klein E.A., et al. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006, 2:e25.
17. Rothman K.J., Greenland S. Causation and causal inference in epidemiology. Am J Public Health 2005, 95(Suppl 1):S144-S150.
18. Greenland S., Robins J.M., Pearl J. Confounding and collapsibility in causal inference. Stat Sci 1999, 14:29-48.
19. Hill A.B. Environment and disease: association or causation. Proc R Soc Med 1965, 58:295-300.
20. Hofler M. The Bradford Hill considerations on causality: a counterfactual perspective. Emerg Themes Epidemiol 2005, 2:11.
21. Falkow S. Molecular Koch's postulates applied to bacterial pathogenicity-a personal recollection 15 years later. Nat Rev Microbiol 2004, 2:67-72.
22. Evans A.S. Causation and disease: the Henle-Koch postulates revisited. Yale J Biol Med 1976, 49:175-195.
23. Bunge M. Causality the place of the causal principle in modern science 1959, Meridian Books, Cleveland/New York.
24. Perz J.F., Armstrong G.L., Farrington L.A., Hutin Y.J., Bell B.P. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006, 45:529-538.
25. Menzies P. Counterfactual theories of causation. Stanford encyclopedia of philosophy 2009, Fall 2009 ed.
26. Henle J., Rosen G. Jacob Henle on miasmata and contagia 1938, The Johns Hopkins Press, Baltimore.
27. Evans A.S. Causation and disease: a chronological journey. Am J Epidemiol 1978, 108:249-258.
28. Koch R. An address on cholera and its bacillus. Br Med J 1884, 2:453-459.
29. Wildner M., Hofman A. Re: Epidemiologic interactions, complexity, and the lonesome death of Max von Pettenkofer. Am J Epidemiol 2008, 168:119-120. [author reply 20-1].
30. Morabia A. Epidemiologic interactions, complexity, and the lonesome death of Max von Pettenkofer. Am J Epidemiol 2007, 166:1233-1238.
31. Huebner R.J. Criteria for etiologic association of prevalent viruses with prevalent diseases; the virologist's dilemma. Ann N Y Acad Sci 1957, 67:430-438.
32. Moore P.S., Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer 2010, 10:878-889.
33. Darby S.C., Ewart D.W., Giangrande P.L., Dolin P.J., Spooner R.J., Rizza C.R. Mortality before and after HIV infection in the complete UK population of haemophiliacs. UK Haemophilia Centre Directors' Organisation. Nature 1995, 377:79-82.
34. Rivers T.M. Viruses and Koch's postulates. J Bacteriol 1937, 33:1-12.
35. Fredericks D.N., Relman D.A. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev 1996, 9:18-33.
36. Giraldo G., Kourilsky F.M., Henle W., Mike V., Huraux J.M., Andersen H.K., et al. Antibody patterns to herpesviruses in Kaposi's sarcoma: serological association of European Kaposi's sarcoma with cytomegalovirus. Int J Cancer 1975, 15:839-848.
37. Walter P.R., Philippe E., Nguemby-Mbina C., Chamlian A. Kaposi's sarcoma: presence of herpes-type particles in a tumor specimen. Hum Pathol 1984, 15:1145-1146.
38. Kaposi M. Idiopathic multiple pigmented sarcoma of the skin. Arch Dermatol Syphil 1872, 4:265-273. [English translation in CA: A Cancer Journal for Clinicians, New York 1982; 32: 342-7].
39. Cook-Mozaffari P., Newton R., Beral V., Burkitt D.P. The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer 1998, 78:1521-1528.
40. Penn I. Kaposi's sarcoma in organ transplant recipients: report of 20 cases. Transplantation 1979, 27:8-11.
41. Safai B., Miké V., Giraldo G., Beth E., Good R.A. Association of Kaposi's sarcoma with second primary malignancies. Cancer 1980, 45:1472-1479.
42. Ulbright T.M., Santa Cruz D.J. Kaposi's sarcoma: relationship with hematologic, lymphoid, and thymic neoplasia. Cancer 1981, 47:963-973.
43. Ambinder R.F., Newman C., Hayward G.S., Biggar R., Melbye M., Kestens L., et al. Lack of association of cytomegalovirus with endemic African Kaposi's sarcoma. J Infect Dis 1985, 156:133.
44. Huang Y.Q., Li J.J., Rush M.G., Poiesz B.J., Nicolaides A., Jacobson M., et al. HPV-16-related DNA sequences in Kaposi's sarcoma. Lancet 1992, 339:515-518.
45. Wang R.Y-H., Shih J.W-K., Weiss S.H., Grandinetti T., Pierce P.F., Lange M., et al. Mycoplasma penetrans infection in homosexual men with AIDS: high seroprevalence and association with Kaposi's sarcoma. Clin Infect Dis 1993, 17:724-729.
46. Palca J. Kaposi's sarcoma gives on key fronts. Science 1992, 255:1352-1354.
47. Ensoli B., Barillari G., Gallo R.C. Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma. Immunol Rev 1992, 127:147-155.
48. Beral V., Peterman T.A., Berkelman R.L., Jaffe H.W. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection. Lancet 1990, 335:123-128.
49. Lisitsyn N., Lisitsyn N., Wigler M. Cloning the differences between two complex genomes. Science 1993, 259:946-951.
50. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 265:1865-1869.
51. Cesarman E., Moore P.S., Rao P.H., Inghirami G., Knowles D.M., Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995, 86:2708-2714.
52. Moore P.S., Gao S.J., Dominguez G., Cesarman E., Lungu O., Knowles D.M., et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol 1996, 70:549-558.
53. Renne R., Zhong W., Herndier B., McGrath M., Abbey N., Kedes D., et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 1996, 2:342-346.
54. Russo J.J., Bohenzky R.A., Chien M.C., Chen J., Yan M., Maddalena D., et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 1996, 93:14862-14867.
55. Sarid R., Olsen S.J., Moore P.S. Kaposi's sarcoma-associated herpesvirus: epidemiology, virology, and molecular biology. Adv Virus Res 1999, 52:139-232.
56. Boshoff C., Whitby D., Hatziionnou T., Fisher C., van der Walt J., Hatzakis A., et al. Kaposi's sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995, 345:1043-1044.
57. Su I-J., Hsu Y-S., Chang Y-C., Wang I-W. Herpesvirus-like DNA sequence in Kaposi's sarcoma from AIDS and non-AIDS patients in Taiwan. Lancet 1995, 345:722-723.
58. Moore P.S., Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma lesions from persons with and without HIV infection. N Engl J Med 1995, 332:1181-1185.
59. Cesarman E., Chang Y., Moore P.S., Said J.W., Knowles D.M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995, 332:1186-1191.
60. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995, 86:1276-1280.
61. Miller G., Rigsby M.O., Heston L., Grogan E., Sun R., Metroka C., et al. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med 1996, 334:1292-1297.
62. Gao S.J., Kingsley L., Li M., Zheng W., Parravicini C., Ziegler J., et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996, 2:925-928.
63. Martin J.N., Ganem D.E., Osmond D.H., Page-Shafer K.A., Macrae D., Kedes D.H. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998, 338:948-954.
64. Kedes D.H., Operskalski E., Busch M., Kohn R., Flood J., Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996, 2:918-924.
65. Whitby D., Howard M.R., Tenant-Flowers M., Brink N.S., Copas A., Boshoff C., et al. Detection of Kaposi's sarcoma-associated herpesvirus (KSHV) in peripheral blood of HIV-infected individuals predicts progression to Kaposi's sarcoma. Lancet 1995, 364:799-802.
66. Moore P.S., Kingsley L.A., Holmberg S.D., Spira T., Gupta P., Hoover D.R., et al. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS 1996, 10:175-180.
67. Gao S.-J., Kingsley L., Hoover D.R., Spira T.J., Rinaldo C.R., Saah A., et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996, 335:233-241.
68. Renwick N., Halaby T., Weverling G.J., Dukers N.H., Simpson G.R., Coutinho R.A., et al. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS 1998, 12:2481-2488.
69. Moore P.S., Chang Y. Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV. Trends Genet 1998, 14:144-150.
70. Moore P.S., Chang Y. Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin. Annu Rev Microbiol 2003, 57:609-639.
71. Martin D.F., Kuppermann B.D., Wolitz R.A., Palestine A.G., Li H., Robinson C.A. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. N Engl J Med 1999, 340:1063-1070.
72. Cohen J. Controversy: is KS really caused by new herpesvirus?. Science 1994, 268:1847-1848.
73. Rady P.L., Yen A., Rollefson J.L., Orengo I., Bruce S., Hughes T.K., et al. Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients. Lancet 1995, 345:1339-1340.
74. Lin J.-C., Lin S.-C., Mar E.-C., Pellett P.E., Stamey F.R., Stewart J.A., et al. Is Kaposi's sarcoma-associated herpesvirus detectable in semen of HIV-infected homosexual men. Lancet 1995, 346:1601-1602.
75. Lennette E.T., Blackbourn D.J., Levy J.A. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996, 348:858-861.
76. Boshoff C., Weiss R.A. Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci 2001, 356:517-534.
77. Hayward G.S. KSHV strains: the origins and global spread of the virus. Semin Cancer Biol 1999, 9:187-199.
78. Fu B., Sun F., Li B., Yang L., Zeng Y., Sun X., et al. Seroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Xinjiang, China. J Med Virol 2009, 81:1422-1431.
79. Wang X., He B., Zhang Z., Liu T., Wang H., Li X., et al. Human herpesvirus-8 in northwestern China: epidemiology and characterization among blood donors. Virol J 2010, 7:62.
80. Engels E.A., Pfeiffer R.M., Goedert J.J., Virgo P., McNeel T.S., Scoppa S.M., et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006, 20:1645-1654.
81. Feng H., Shuda M., Chang Y., Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008, 319:1096-1100.
82. Engels E.A., Frisch M., Goedert J.J., Biggar R.J., Miller R.W. Merkel cell carcinoma and HIV infection. Lancet 2002, 359:497-498.
83. Koljonen V., Kukko H., Tukiainen E., Bohling T., Sankila R., Pukkala E., et al. Incidence of Merkel cell carcinoma in renal transplant recipients. Nephrol Dial Transplant 2009, 24:3231-3235.
84. Na R., Grulich A.E., Meagher N.S., McCaughan G.W., Keogh A.M., Vajdic C.M. Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients. Am J Transplant 2013, 13:174-183.
85. Lemos B., Nghiem P. Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol 2007, 127:2100-2103.
86. Feng H., Taylor J.L., Benos P.V., Newton R., Waddell K., Lucas S.B., et al. Human transcriptome subtraction by using short sequence tags to search for tumor viruses in conjunctival carcinoma. J Virol 2007, 81:11332-11340.
87. MacConaill L., Meyerson M. Adding pathogens by genomic subtraction. Nat Genet 2008, 40:380-382.
88. Shuda M., Feng H., Kwun H.J., Rosen S.T., Gjoerup O., Moore P.S., et al. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci U S A 2008, 105:16272-16277.
89. Rodig S.J., Cheng J., Wardzala J., DoRosario A., Scanlon J.J., Laga A.C., et al. Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus. J Clin Invest 2012, 122:4645-4653.
90. Shuda M., Arora R., Kwun H.J., Feng H., Sarid R., Fernandez-Figueras M.T., et al. Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer 2009, 125:1243-1249.
91. Sihto H., Kukko H., Koljonen V., Sankila R., Bohling T., Joensuu H. Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst 2009, 101:938-945.
92. Chang Y., Moore P.S. Merkel cell carcinoma: a virus-induced human cancer. Annu Rev Pathol 2012, 7:123-144.
93. Faust H., Andersson K., Ekstrom J., Hortlund M., Robsahm T.E., Dillner J. Prospective study of Merkel cell polyomavirus and risk of Merkel cell carcinoma. Int J Cancer 2013, 134:844-848.
94. Tolstov Y.L., Pastrana D.V., Feng H., Becker J.C., Jenkins F.J., Moschos S., et al. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer 2009, 125:1250-1256.
95. Pastrana D.V., Tolstov Y.L., Becker J.C., Moore P.S., Chang Y., Buck C.B. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog 2009, 5:e1000578.
96. Viscidi R.P., Rollison D.E., Sondak V.K., Silver B., Messina J.L., Giuliano A.R., et al. Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus. Clin Vaccine Immunol 2011, 18:1737-1743.
97. Faust H., Pastrana D.V., Buck C.B., Dillner J., Ekstrom J. Antibodies to Merkel cell polyomavirus correlate to presence of viral DNA in the skin. J Infect Dis 2011, 203:1096-1100.
98. Chen T., Hedman L., Mattila P.S., Jartti T., Ruuskanen O., Soderlund-Venermo M., et al. Serological evidence of Merkel cell polyomavirus primary infections in childhood. J Clin Virol 2011, 50:125-129.
99. Touze A., Gaitan J., Arnold F., Cazal R., Fleury M.J., Combelas N., et al. Generation of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies. J Clin Microbiol 2010, 48:1767-1770.
100. Schowalter R.M., Pastrana D.V., Pumphrey K.A., Moyer A.L., Buck C.B. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 2010, 7:509-515.
101. Laude H.C., Jonchère B., Maubec E., Carlotti A., Marinho E., Couturaud B., Peter M., Sastre-Garau X., Avril M.F., Dupin N., Rozenberg F. Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma. PLoS Pathog 2010, 6:e1001076. 10.1371/journal.ppat.1001076.
102. Tolstov Y.L., Knauer A., Chen J.G., Kensler T.W., Kingsley L.A., Moore P.S., et al. Asymptomatic primary Merkel cell polyomavirus infection among adults. Emerg Infect Dis 2011, 17:1371-1380.
103. Higaki-Mori H., Kuwamoto S., Iwasaki T., Kato M., Murakami I., Nagata K., et al. Association of Merkel cell polyomavirus infection with clinicopathological differences in Merkel cell carcinoma. Hum Pathol 2012, 43:2282-2291.
104. Renwick N., Cekan P., Masry P.A., McGeary S.E., Miller J.B., Hafner M., et al. Multicolor microRNA FISH effectively differentiates tumor types. J Clin Invest 2013, 123:2694-2702.
105. Xie H., Lee L., Caramuta S., Hoog A., Browaldh N., Bjornhagen V., et al. MicroRNA expression patterns related to Merkel cell polyomavirus infection in human Merkel cell carcinoma. J Invest Dermatol 2013, 10.1038/jid.2013.355.
106. Houben R., Adam C., Baeurle A., Hesbacher S., Grimm J., Angermeyer S., et al. An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells. Int J Cancer 2012, 130:847-856.
107. Houben R., Shuda M., Weinkam R., Schrama D., Feng H., Chang Y., et al. Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J Virol 2010, 84:7064-7072.
108. Shuda M., Chang Y., Moore P.S. Merkel cell polyomavirus positive Merkel cell carcinoma requires viral small T antigen for cell proliferation. J Invest Dermatol 2013, 10.1038/jid.2013.483.
109. Shuda M., Kwun H.J., Feng H., Chang Y., Moore P.S. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. J Clin Invest 2011, 121:3623-3634.
110. Kwun H.J., Shuda M., Feng H., Camacho C.J., Moore P.S., Chang Y. Merkel cell polyomavirus small T antigen controls viral replication and oncoprotein expression by targeting the cellular ubiquitin ligase SCF (Fbw7). Cell Host Microbe 2013, 14:125-135.
111. Arora R., Chang Y., Moore P.S. MCV and Merkel cell carcinoma: a molecular success story. Curr Opin Virol 2012, 2:489-498.
112. Vogelstein B., Papadopoulos N., Velculescu V.E., Zhou S., Diaz L.A., Kinzler K.W. Cancer genome landscapes. Science 2013, 339:1546-1558.
113. DeCaprio J.A., Garcea R.L. A cornucopia of human polyomaviruses. Nat Rev Microbiol 2013, 11:264-276.
114. Kelly G.L., Rickinson A.B. Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy. Hematol Am Soc Hematol Educ Program 2007, 27:7-84.
115. Shah K.M., Young L.S. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma. Clin Microbiol Infect 2009, 15:982-988.
116. Liu Y., Chang C.C., Marsh G.M., Wu F. Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis. Eur J Cancer 2012, 48:2125-2136.
117. Weiss R.A. The discovery of endogenous retroviruses. Retrovirology 2006, 3:67.
118. Murgia C., Pritchard J.K., Kim S.Y., Fassati A., Weiss R.A. Clonal origin and evolution of a transmissible cancer. Cell 2006, 126:477-487.
119. Phillips C.V., Goodman K.J. Causal criteria and counterfactuals; nothing more (or less) than scientific common sense. Emerg Themes Epidemiol 2006, 3:5.
120. Goodwin E.C., DiMaio D. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc Natl Acad Sci U S A 2000, 97:12513-12518.
121. Godfrey A., Anderson J., Papanastasiou A., Takeuchi Y., Boshoff C. Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. Blood 2005, 105:2510-2518.
122. Pearl J. Causality: models, reasoning and inference 2010, Cambridge University Press, New York, NY. 2nd ed.
123. Efron B. Mathematics. Bayes' theorem in the 21st century. Science 2013, 340:1177-1178.
124. Khoury J.D., Tannir N.M., Williams M.D., Chen Y., Yao H., Zhang J., et al. Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq. J Virol 2013, 87:8916-8926.